COVID-19 Funding Opportunities & FAQs

The availability of COVID-19 grants and funding opportunities to support research is rapidly evolving. Many investigators also have questions about how to deal with grant program interruptions. Listed below are links to information/FAQs from several major federal agencies on how to deal with grant interruptions. Following that is a collection of COVID-19 funding opportunities to support research from a variety of federal agencies, foundations, and organizations. Check back often for updated lists.

Please contact Lori Uttech-Hanson to share relevant funding sources at

Dealing with Grant Interruptions, Delays or Flexibilities due to COVID

Many UW-Madison researchers and research administrative staff have questions about how to deal with grant interruptions, delays, or flexibilities due to the pandemic and temporary closure of facilities. The NIH has a very informative webpage dedicated to FAQs, which tend to direct you to your Program Officer in most cases (see link below). All federal agencies understand what is going on, but may have less thorough information than NIH. If you find your question is not addressed on the agency’s website, it is advisable to email the Program Officer, copying your RSP accountant.  RSP also has different sponsors’ COVID-19 information posted on their website. Please click on the links below for guidance and FAQs related to grant delays and interruptions from several major funders and additional information posted on the RSP website:

Funding Opportunities Related to COVID-19

This is an accordion element with a series of buttons that open and close related content panels.

Grant Database Lists (Free Access to Collections of Funding Announcements)

Ex Libris Research Professional:  The Ex Libris Research Professional together with Pivot® funding services are providing free access to a list of select funding opportunities related to combatting the coronavirus and COVID-19. By raising awareness of these resources, which are offered from a wide range of global funders, they hope to help researchers expand their scholarly efforts to understand and contend with this global pandemic.
Link is:

Grant Forward: GrantForward has provided a free list of grants related to addressing COVID-19 ranging from small foundation to large-scale federal research grants in an effort to help researchers and others find science-based solutions to address this global pandemic.
Link is:

GrantStation: GrantStation’s list includes funding opportunities for nonprofits, small businesses, journalists, and artists.
Link is:

InfoEd Global:  InfoEd Global shares this library of COVID-19 funding opportunities and resources for researchers and the broader community at large. This site is updated daily.
Link is:  

National Institutes of Health: Funding specific to COVID-19 (also in table below with more information).
Link is: 

Pivot: Pivot has given free access to a list of COVID-19 related funding sources, and they are updating the list weekly.
Link is:

WI Center for Technology Commercialization: The CTC has posted a list of federal agencies that are supporting research and development in response to the coronavirus.  Many of these agencies are included in the panels below on this medRAMP website, with information on specific funding announcements.
Link is:

Stermlyne Research Software: Streamlyne’s intelligent natural language processing tool enables researchers to locate articles on SARS-CoV-2  and related viruses quickly and efficiently within the COVID-19 Open Research Dataset (CORD-19) created by the Allen Institute for AI, in partnership with several tech companies and the OSTP.  The dataset is linked to the World Health Organization (WHO) database of publications on coronavirus disease and other resources.  The website also provides a sample list of some of the most promising COVID-19 research efforts at universities and independent research institutions.
Link is:

SPIN infoED Funding Database: infoEd Global is proud to be able to share this library of COVID-19 funding opportunities and resources with colleagues in the research realm and the broader community at large.
Link is:

InnoCentive COVID-19 Challenges: This page is exclusively for Coronavirus related challenges. InnoCentive and Wazoku are initiating the first of these challenges and are already working with organizations to design and post others. Each challenge will have a specific problem area defined for either required Solutions or Ideas to be submitted. Clients from the public and private sectors will be named in the challenges as having provided support, funding and reviewing expertise for solutions submitted.
• Link is:

National Institutes of Health

In addition to the table below, NIH COVID-19 related announcements are posted here, with COVID-19 resources found at this link. 

National Institutes of Health

wdt_ID Sponsor Program Funding Deadline Notice Activity Code
1 NIA, NIAID, NIDDK, NIDA, NIMH, NIEHS, NICHD, NIAAA, NIBIB, NHGRI, NIMHD, NCATS, NIDCH, NCI, NIDCR Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement – Clinical Trial Optional) Must reflect your needs Varies by awarding IC PA-18-935
5 NIDA NOSI regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus $100K direct costs/yr 3/19/2020 -Applications accepted through 3/31/2021 NOT-DA-20-047 Admin Supp
7 NIMH, NIA, NIAAA, NIMHD, (ODP) Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus Contact program officer 3/27/2020 - Applications accepted through 4/15/2021 NOT-MH-20-047 Admin Supp
8 NIAID (UPDATED) Select Research Areas for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) Check RFA(s) within 6/16/2020 - Application accepted through 9/08/2021 NOT-AI-20-051 (Replaces NOT-AI-20-031) R03, R21, Admin Supp, R01, R43/R44, R41/R42
9 NIA, NIMH, NIAAA NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) Must reflect your needs 5/1/21 (due dates from 4/6/20-5/1/21) NOT-AG-20-022 Admin Supp
10 OBSSR, NHLBI, NIA, NIAAA, NIDDK, NIEHS, NCCIH, NCI, (ODP, ORWH) Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences $200,000 (direct costs) 3/31/2021 (Applications accepted from 4/13/20 to 3/31/21) NOT-OD-20-097 Admin Supp
13 NIHMD, NIA, NIMH Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health Disparities $125,000 (direct costs) 5/1/2020 - Applications accepted through 5/1/2021 NOT-MD-20-019 Admin Supp
14 NIEHS NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) Must reflect your needs 5/1/2020, 6/1/2020, 7/01/2020, 8/03/2020, 9/01/2020, 10/01/2020, 11/02/2020, 12/01/2020, 1/04/2021, 2/01/2021, 3/01/2021, 4/01/2021, 5/03/2021 NOT-ES-20-020 Admin Supp, R21
15 NCATS Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need Must reflect your needs 6/1/2021 (rolling deadline from 12/17/20-6/1/21) NOT-TR-20-011 Admin Supp, U01, R21, U54
17 NIAID, NIA Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required) Not limited 5/13/2020; 9/13/2020; 1/13/2021; 5/13/2021; 9/13/2021; 1/13/2022; 5/13/2022; 9/13/2022; 1/13/2023 PAR-20-139 R01
Sponsor Program Funding Deadline Notice Activity Code

Agency for Healthcare Research and Quality

  • Special Emphasis Notice (SEN): AHRQ Announces Interest in Health Services Research to Address Substance Use Disorder Epidemic (NOT-HS-21-010): The purpose of this Special Emphasis Notice (SEN) is to inform the research community that the Agency for Healthcare Research and Quality is interested in receiving health services research grant applications to advance our nation’s understanding of the substance use disorder crisis and provide solutions for addressing it. In this SEN, AHRQ is interested in health services research to prevent, identify and treat substance use disorders with a high degree of interest in applications that respond to the following three specific areas of focus: (1) Dissemination and implementation of evidence-based, non-pharmacological and behavioral interventions that can treat multiple substances or polysubstance use in ambulatory care and primary care settings, with a particular interest in substances for which pharmacological treatments are not available. (2) Development and testing of healthcare services interventions in primary care and ambulatory care settings to address substance use disorder that consider the social, environmental, economic and psychological factors that contribute to substance use disorder. Examples include care coordination, integration of substance use services in ambulatory care settings, or integration of population health approaches with primary care. Applications that take advantage of the natural experiment caused by the COVID-19 pandemic to examine how changes in service delivery (such as expanded use of telehealth) affect access to care, quality of care, and health inequities are particularly welcome. (3) Understanding and addressing the effect of substance use disorder on whole person health and the development and/or management of other chronic conditions.
    The Agency encourages research teams to submit applications in response to this emphasis using AHRQ’s standing R18, R03, and R01 funding mechanisms (PA-18-793PA-18-794PA-18-795). AHRQ also is interested in receiving career development awards (PA-20-067 and PA-17-232) that propose developing generalizable health service research skills through projects related to the substance use disorder crisis. Additionally, AHRQ has interest in receiving dissertation award grant proposals that relate to the substance use disorder crisis (PA-18-765).

Department of Defense

Department of Defense

wdt_ID Sponser Program Funding Deadline
1 DoD Request for Information for PPE in response to COVID-19 N/A 3/24/2020 (information accepted on a rolling basis)
11 DOD Defense Advanced Research Projects Agency (DARPA)
Biological Technologies Office (BTO)
Biological Technologies (HR001120S0044) $250,000 4/22/2021
12 DoD Dept. of the Army - USAMRAA Department of Defense HIV/AIDS Prevention Program - W81XWH-21-DHAPP See NOFO 9/23/2022
13 DoD Defense Threat Reduction Agency Strategic Trends Division Broad Agency Announcement (BAA) HDTRA1-20-S-0002BAA $350,000 (Offers may submit a White Paper package to any of the BAA’s Thrust Areas of research at any time. If an Offer’s Phase I package is approved, the Offer will be invited to submit a Phase II package (Proposal). 3/02/2025

Patient-Centered Outcomes Research Institute

  • Engagement Award Special Cycle: Building Capacity for PCOR/CER for Topics Related to COVID-19: These Awards support projects that encourage active, meaningful involvement of patients, caregivers, clinicians, and other healthcare stakeholders as integral members of the patient-centered outcomes research/comparative clinical effectiveness research (PCOR/CER) enterprise. This special funding opportunity will support projects that enable organizations and communities to build their capacity and skills to participate across all phases of the PCOR/CER process on topics that address health outcomes related to COVID-19. Projects will also provide an understanding of the impact of stakeholder engagement strategies within different settings and stakeholder groups focused on this special area of interest.  This is an opportunity to explore and address the urgent and unique needs to build capacity for stakeholder engagement in PCOR/CER specifically related to:
    -Long-term effects of post-acute COVID-19;
    -Impact of COVID-19 on disproportionately affected populations;
    -Impact of COVID-19 on social isolation and loneliness (mental health and well-being);
    -Engaging, educating, and promoting informed decision making around COVID-19 vaccines; and
    -Other relevant topics related to COVID-19 health outcomes with appropriate justification will also be considered.

Deadline: May 24, 2021; Award $200,000 total for up to 18 months 

  • Engagement Award Special Cycle: Building Capacity for PCOR/CER in Intellectual and Developmental Disabilities:  This is an opportunity to build capacity for stakeholder engagement with PCOR/CER in IDD on topics such as:
    -Addressing health equity and advancing IDD health outcomes for vulnerable populations;
    -Leveraging community-based and patient-centered models of care delivery;
    -Challenges related to clinical care delivery and access:
    -Telehealth solutions;
    -Transition to adulthood;
    -Caregiver needs and access to wraparound support;
    -Patient needs and preferences; and
    -Other relevant topics related to IDD health outcomes with appropriate justification are welcomed.

Deadline: May 24, 2021; Award $250,000 total for up to 2 years

Centers for Disease Control and Prevention

  • CDC Enhancing Global Health Security: Strengthening Public Health Surveillance Systems and Preparedness Globally (CDC-RFA-GH21-2174).  Activities under this Notice of Funding Opportunity (NOFO) should focus on protecting and improving public health globally by: 1) strengthening public health surveillance systems; 2) improving the public health surveillance workforce; 3) improving the interface between public health disease surveillance and laboratory systems; 4) reinforcing emergency surveillance preparedness; 5) enhancing electronic disease surveillance platforms and systems; and 6) enhancing the use of surveillance data for public health action. This NOFO is intended to support global health security partners to develop or continue the implementation of surveillance activities that focus on protecting and improving public health globally through strategic planning, policy, strengthening surveillance capacities and systems through partnerships. These should build and improve regional and country capacities to prevent, detect, respond and control infectious disease outbreaks, strengthen border health security and mitigate public health events of international concern (PHEICs) or other global health threats.
    Estimated Due Date: 1/29/2021; Award Ceiling $20,000,000
  • Capacity Building for Global, Regional, and National Immunization Programs (CDC-RFA-GH21-2101): The purpose of this NOFO is to strengthen capacity and performance of global, regional and national immunization programs in priority countries to achieve vaccine preventable disease (VPD) control, elimination and eradication targets (i.e., polio eradication, measles and rubella elimination), reduce VPD-related morbidity and mortality, and address emerging public health threats such as coronavirus disease 2019 (COVID-19).
    Deadline: 4/20/2021; Award Ceiling: $13,000,000
  • Community Health Workers for COVID Response and Resilient Communities (CCR) (CDC-RFA-DP21-2109):  This Notice of Funding Opportunity (NOFO) supports this work through training and deployment of community health workers (CHWs) and by building and strengthening community resilience to fight COVID-19 through addressing existing health disparities in the population.
    Estimated Post Date: 2/23/2021; Estimated Due Date: 4/24/2021; Award Ceiling: $5,000,000
  • Community Health Workers for COVID Response and Resilient Communities (CCR) -Evaluation and Technical Assistance (ETA) (CDC-RFA-DP21-2110):  This three-year opportunity provides funds to conduct a national evaluation of the Community Health Workers for COVID Response and Resilient Communities (CCR) program, DP21-2110 and provide training and technical assistance (TA) to CCR recipients. This program has two components: A) conduct a national evaluation of the CCR and B) deliver training and TA to CCR recipients.
    Estimated Post Date: 3/23/2021; Estimated Due Date: 5/22/2021; Award Ceiling: $3,000,000
  • Community Health Access and Rural Transformation (CHART) (CMS-2G2-21-001): The Community Health Access and Rural Transformation (CHART) Model is a voluntary payment model designed to meet the needs of rural communities. The model will test whether aligned financial incentives, increased operational flexibility, and robust technical support promote the capacity of rural healthcare providers to implement effective healthcare delivery system redesign on a broad scale. This opportunity is for the Community Transformation Track. Under the Community Transformation Track, award recipients will receive funding and a programmatic framework to assess the needs of their Community and implement healthcare delivery system redesign.
    Due Date: 5/11/2021; Award Ceiling: $5,000,000 
  • Global Healthcare Detection and Response (CDC-RFA-CK21-2104):  This NOFO will enhance detection and response to emerging infectious disease threats in healthcare facilities through a global collaborative network approach. The purpose of the network is to rapidly detect and actively contain emerging infectious disease threats in healthcare settings by setting targeted priority goals for prevention, including pathogens or conditions, and working collaboratively to achieve these goals through detection and response. These objectives will be met through implementing detection and response services at local, national, and regional levels; evaluating and continually improving implementation; monitoring and assessing impact; conducting implementation science and innovation to inform strategies; enhancing laboratory capacity at key participating labs; and actively facilitating learning to other partners in the country/region.
    Dude Date: 5/26/2021; Award Ceiling: None stated

Other Department of Health and Human Services

National Science Foundation

National Science Foundation

wdt_ID Sponsor Program Funding Deadline
1 NSF RAPID: Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19) $200,000 Check with program officers
2 NSF Dear Colleague Letter: Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 (COVID-19) $200,000 (RAPID) & supplemental funding requests Check with program officers
4 NSF Civic Innovation Challenge (CIVIC) $50,000 for Stage 1; $1,000,000 for Stage 2 8/03/2020 - Stage 1 (Planning); 3/31/2021 - Stage 2
5 NSF Ecology and Evolution of Infectious Diseases* $2,500,000 total 11/17/2021 & annually thereafter
6 NSF Smart and Connected Communities (S&CC) (21-535) • Integrative Research: Track 1 - $1,500,001-$2,500,000; Track 2 $1,500,000
• Planning: $150,000
• Virtual Organization: $250,000/year
7 NSF Research on Emerging Technologies for Teaching and Learning (RETTL) (20-612) $850,000 1/25/2021; 10/18/2021; 10/17/2022
8 NSF Secure and Trustworthy Cyberspace (SaTC) (21-500 ) CORE & TPP: Small - $500,000; Medium -$500,000 to $1,200,000
CORE: Large - $1,200,001-$3,000,000
EDU: $400,000 to $500,000
Large: 1/21/2021-1/29/2021
Small/Medium/EDU: 10/01/2020-9/30/2021
11 NSF Dynamics of Integrated Socio-Environmental Systems (DISES) (20-579 ) DISES Research Projects: $1,600,000
DISES-RCN Awards: $500,000
11/21/2021 & annually thereafter
12 NSF Innovations in Graduate Education (IGE) Program (20-595) $1,000,000 March 25, 2022; March 25, Annually Thereafter
13 NSF Dear Colleague Letter: Sentinel Cells for Surveillance and Response to Emergent Infectious Diseases (Sentinels) (NSF 20-105) Based on applicable program (NSF 21-509; PD 20-7909, NSF PD 20-1491) Rolling deadlines

Department of Agriculture

Department of Agriculture

wdt_ID Sponsor Program Name Funding Deadline
5 National Institute of Food and Agriculture Rural Health and Saftey Education Department of Agriculture Unspecified 4/29/2021

Other Sponsors & Funding Opportunities

Other Sponsors

wdt_ID Sponsor Program Funding Deadline
1 Mozilla COVID-19 Solutions Fund $50,000 Applications accepted on a rolling basis
2 Department of Energy Invitation for COVID-19 scientific questions DOE Resources 3/18/2020 - Review starts 3/18 but applications accepted on a rolling basis
11 Wellcome Trust & UK Department for International Development Epidemic Preparedness: COVID-19 funding call Up to £2 million available Currently closed
12 Merck KGaA (Germany) Research Grant for Pandemic Preparedness $1,500,000 ($500,000 €/yr for 3 yrs) Applications accepted on a rolling basis
25 Autism Speaks COVID19_Resource_Call.pdf Not Applicable Not specified
27 Biogen Foundation (review request guidelines) COVID-19 Response Not specified Accepting applications - no due date specified
29 Draper Richards Kaplan Foundation DRK Covid-19 Urgent Response Initiative (CURI) $50,000-$100,000 (TBD - CURI invests 25% max of total) Rolling deadline
60 U.S. International Development Finance Corporation Global Health and Prosperity Initiative $5,000,000 to $500,000,000 No deadline; applications accepted on a rolling basis
62 Gates Foundation COVID-19 Therapeutics Accelerator Share ideas Ongoing
63 COVID-19 Early Treatment Fund (CETF) Funding for Outpatent Trials Up to $1,000,000 Currently accepting applications

The Robert Wood Johnson Foundation

Robert Wood Johnson Foundation (RWJF)

wdt_ID Sponsor Program Funding Deadline
4 RWJF RWJF Health Data for Action: (Data Access Award) -Successful applicants granted access to the selected data set at no cost to the grantee.
-$100,000 for First-Time External Funding Recipient Awards
12/17/2020 for brief proposal; 4/15/2021 for invited full proposal
6 RWJF Evidence for Action: Investigator-Initiated Research to Build a Culture of Health Not specified Rolling
7 RWJF Pioneering Ideas: Exploring the Future to Build a Culture of Health No specified Rolling
8 RWJF Policies for Action: Public Policy Research to Advance Racial Equity and Racial Justice Not defined; however average award is $250,000 ($2M available) 11/24/2020 for Letter of Intent; 4/07/2021 for Full Application
9 RWJF Systems for Action: Systems and Services Research to Build a Culture of Health $500,000 4/30/2021 for Letter of Intent (optional); 6/09/2021 for full proposal

Internal UW-Madison Funding Opportunities

UWCCC BioBank – COVID 19-Related Blood Samples for Research

Internal UW-Madison Opportunities

wdt_ID Sponsor Program Funding Deadline
1 Wisconsin Partnership Program COVID-19 Response Grant $200,000 Letter of Intent due 4/08/2021
4 UWCCC Translational Science BioCore BioBank, UW SMPH & Wisconsin Partnership Program COVID-19 BioBank Initiative Request for Proposals Access to UWCCC BioBank resources (samples, clinical or survey data) to further COVID-19 research efforts Applications reviewed monthly, and approvals granted on a rolling basis
6 UW ICTR Novel Methods Award $50,000 Deadline has passed
7 UW ICTR Clinical & Community Outcomes Research $75,000 Deadline has passed
8 UW ICTR Collaborative Health Equity Research $50,000 Deadline has passed
9 UW ICTR Evidence to Implementation $52,500 Deadline has passed
10 UW ICTR Marshfield Clinic/Marshfield Clinic-UW Award $75,000 Deadline has passed
11 UW ICTR Stakeholder and Patient Engaged Research $100,000 Deadline has passed
12 UW ICTR Translational Basic & Clinical Research Pilot Awards $50,000 12/21/2020 for Letter of Intent; 2/22/2021 for Full Application
13 Wisconsin Alumni Research Foundation Research Forward $500,000 12/21/2020 for Abstract; 2/01/2021 for Full Proposal

Fast Grants Funding for COVID-19 Science

Note: Applications to Fast Grants is currently paused due to receipt of a very large number of qualified submissions. They may be reopened again in the future. Please go to the Fast Grants website to sign up if you’d like to be notified when they are reopened.
• Link is:

About Fast Grants:

Science funding mechanisms are too slow in normal times and may be much too slow during the COVID-19 pandemic. Fast Grants are an effort to correct this. If you are a scientist at an academic institution currently working on a COVID-19 related project and in need of funding, Fast Grants invites you to apply for a grant. Fast Grants are $10k to $500k and decisions are made in under 48 hours. If approved, you’ll receive payment as quickly as the University can receive it. Below are brief instructions, followed by FAQs:

(A) Instructions:

(1) Fill out the application: The application form should take less than 30 minutes.

(B) Frequently Asked Questions (FAQs)

(1) Who is eligible to apply for a Fast Grant?
You must be:

  • A PI at an academic institution;
  • Already working on a project that could help with the COVID-19 pandemic within the next six months;
  • In need of additional funding to complete the project;
  • Researchers outside the US are eligible for funding.

(2) Why the six month constraint?
Most existing funding bodies focus on supporting longer-term work. Given COVID-19’s human costs, speed is of paramount importance.

(4) Who will make grant decisions?
A panel of biomedical scientists will make funding recommendations to Emergent Ventures.

(5) What can a Fast Grant be used for?
Fast Grants must be used solely to expedite COVID-19-related science. Beyond that, the grant recipient has complete discretion over how it is spent.

(6) What criteria will panelists use?
Fast Grants prefers projects that are cheap (so that funding dollars go further) and that will yield results quickly (during COVID-19, days matter).

(7) Does the grant go to the PI or to the university?
This is at the discretion of the applicant.

(8) When can I apply?
Fast Grants opened at 12:00 Pacific Time on Tuesday, April 7, 2020.  The first round of awards was announced starting on April 12.

(9) What conditions apply?

  • You must use the grant to work on COVID-19-related science.
  • You must send monthly updates, summarizing your progress, for 6 months (can be as simple as a single-paragraph email).
  • You must upload all manuscripts reporting work supported by the grant to a preprint server such as bioRxiv or arXiv upon submission to a peer-reviewed journal.
  • In line with Gates Foundation policy, will pay at most 10% in overhead costs to the university.

(10) How do IP rights work?
Apart from the open science publication requirement above, there are no IP restrictions associated with Fast Grants.

(11) Who administers Fast Grants?
Fast Grants is a part of Emergent Ventures, a project at the Mercatus Center at George Mason University. For Canadian recipients, Fast Grants makes funding recommendations to the Thistledown Foundation.

(12) Will the identities of grant recipients be made public?
This shall be at the recipient’s discretion. Fast Grants will list those who agree to be named and provide regular updates on the total dollars that have been allocated.